Sinobiopharma, Inc. (SNBP) Filed a Form 15
9/1/2011 10:15:41 AM
More...
|
Sinobiopharma, Inc. (SNBP) Announces Agreement to Co-Develop, Manufacture and Promote Eplerenone
8/10/2010 9:50:55 AM
More...
|
Sinobiopharma, Inc. (SNBP) Announces Coverage by Harbinger Research
7/8/2010 10:15:57 AM
More...
|
Sinobiopharma, Inc. (SNBP) Announces Distribution Contracts for Flagship Product Totaling US$8.4 Million
7/6/2010 7:48:47 AM
More...
|
Sinobiopharma, Inc. (SNBP) Announces Third Quarter 2010 Net Income of $0.9 Million
4/19/2010 10:15:58 AM
More...
|
Sinobiopharma, Inc. (SNBP) Announces Second Quarter 2010 Financial Results Revenue Increases to Approximately $2.1 Million; Net Income Increases to Approximately $1.1 Million
1/19/2010 9:38:30 AM
More...
|
Sinobiopharma, Inc. (SNBP) has Production Rights to 23 Drugs Listed in China's National Essential Drugs List
11/16/2009 8:29:36 AM
More...
|
Sinobiopharma, Inc. (SNBP) Presents Highlights from Unaudited First Quarter Financial Results for the 3 Month Period Ended August 31, 2009; Company Posts First Net Profitable Quarter Since the Second Quarter 2008
10/21/2009 10:04:27 AM
More...
|
Sinobiopharma, Inc. (SNBP) Given Certificate for Anti-Coagulant
10/9/2009 1:24:28 PM
More...
|
Sinobiopharma, Inc. (SNBP) Appoints New Chief Financial Officer and Director to the Board
9/30/2009 9:15:51 AM
More...
|
|